At-home predictive care and the shifting patient experience

The eMed platform connects patients with telehealth providers for home testing. [Photo courtesy of eMed]

These medtech developers are advancing remote patient monitoring, virtual care, and AI predictive care.

Robin Farmanfarmaian

The combination of remote patient monitoring (RPM), virtual care and AI predictive care is changing the patient experience. Instead of the occasional clinic visit, people can interact with their healthcare daily and on-demand.

Here are a few of the medtech startups advancing remote, continuous and predictive care. Together, these companies enable truly personalized care, tailored to someone in their daily life and environment.

Remote patient monitoring (RPM)

There are many technology devices that have cleared the FDA and qualify as remote physiologic monitoring under the Medicare CPT codes. Medicare also has remote therapeutic monitoring CPT codes for musculoskeletal …

Read more
  • January 9, 2023
  • 0

VitalConnect wins Frost & Sullivan innovation award for patient monitoring device

[Image from VitalConnect]Frost & Sullivan today recognized VitalConnect with its 2022 North America New Product innovation award for its biosensor technology.

VitalConnect’s biosensor monitors patients and detects multiple health problems.

According to a news release, the platform reduced hospital workloads by enabling home monitoring. Patients who prefer to move freely could use the comfortable, state-of-the-art cardiac monitoring device. It demonstrated the same effectiveness and quality as existing hospital- or home-based devices.

“With an embedded biosensor, the four-inch medical-grade wearable miniaturizes the observational capabilities of an ICU. The unique cardiac monitoring technology simultaneously examines eight essential patient vitals, looking for 21 different cardiac arrhythmias while sending all patient data to a secure cloud in real-time,” said Varun Babu, senior industry analyst at Frost & Sullivan. “Tradition…

Read more
  • December 12, 2022
  • 0